People · Operator
Named in public records as an officer, director or promoter · active 2012–2017 · Other Health Care, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Senzime AB (publ) | — | Other Health Care | Series A | $7.4M | $6.2M | 2017 |
| RetroSense Therapeutics, LLC | — | Biotechnology | Series A | $6.9M | $164.9M | 2015 |
| Fusion Coolant Systems, Inc. | — | Other Technology | Pre-Seed | $551K | $23.4M | 2012 |
Terry Cross at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Terry Cross on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam Gallagher | 1 | 7 |
| Sean Ainsworth | 1 | 5 |
| Andrew McColm | 1 | 3 |
| Thomas Gross | 1 | 3 |
| George Lasezkay | 1 | 2 |
| Kenneth Kousky | 1 | 2 |
| Lena Soderstrom | 1 | 1 |
| Matt Turner | 1 | 1 |
| Sorin Brull | 1 | 1 |
| Steven Skerlos | 1 | 1 |
| Thomas Porter | 1 | 1 |
| Philip Siberg | 1 | 1 |
| Ulf Lindskog | 1 | 1 |
| Adam Dahlberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.